Josh Brumm

Former President and Chief Executive OfficeratDyne Therapeutics· In proxies 2022–2024

Pay in FY2024+141% from the year before · Dyne Therapeutics stock +77.1% the same year

Josh Brumm was paid $14.4M in FY2024 (Dec), up 141%. Dyne Therapeutics stock rose 77.1% that year.

Pay$100 in the stock at the end of FY21 → $198

Pay is from the Summary Compensation Table of each Dyne Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

DYN
Dyne TherapeuticsPublic company · 4 yr
- Former President and Chief Executive Officer2022 – Present · 4 yrStock in role +34%

Roles come from the proxy statements of each company.

Activity

Pay
Dyne Therapeutics President pay rose 141% to $14.4M. The stock rose 77% in FY2024 (Dec).
DEF 14AApr 15, 2025
Pay
Dyne Therapeutics President pay rose 38% to $6.0M. The stock rose 15% in FY2023 (Dec).
DEF 14AApr 5, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?